Cardiology Supplement

Nattokinase

Biologic

form-specific Grade and summary pending review Evidence Grade Strength of published clinical evidence — not a safety rating or a recommendation. How to read this

Dimension Scores

Human Outcome

•

Biomarker Relevance

•

Signal Source Quality

•

Organ Specificity

•

Interaction Certainty

•

Translational Maturity

•

Per-dimension evidence strength is part of the full analysis Unlock full analysis

No indication-level signals recorded yet. The grade above has not been decomposed, so it should be read as a whole-compound assessment rather than a claim about any one indication.

Evidence Summary

A fibrinolytic enzyme from fermented soy, studied in human trials for effects on clotting markers, with one study using an imaging endpoint. There is a dose gap worth knowing about: trials used roughly 10,800 fibrinolytic units, while typical retail products supply 2,000 to 4,000. Evidence generated at the trial dose does not transfer to a product delivering a fraction of it.

Evidence Signals (0)

🔒

Create a free account to see signal-level evidence grades.

Create a free account

Products Containing Nattokinase

No commercial products are currently listed for this molecule.

This evidence profile reflects publicly available research as of October 22, 2026. Evidence grades may change as new research is published. ClinEvident grades the quality of published evidence — it does not evaluate the efficacy of any specific commercial product.